Somatostatin Analogues

From Research to Clinical Practice
Herausgegeben von Hubalewska-Dydejczyk, Alicja; Signore, Alberto; de Jong, Marion; Dierckx, Rudi A.; Buscombe, John

• Gebundenes Buch

Produktbeschreibung

Featuring chapters from specialists in endocrinology, physiology, pathology, and nuclear medicine, this book provides a multidisciplinary approach to a wide variety of issues concerning somatostatin and its analogues. The book:

Provides the most up-to-date coverage of somatostatin analog use in diagnostic and therapy
Integrating the specialties of endocrinology, physiology, pathology, and nuclear medicine, providing the multidisciplinary approach to the topic
Focuses on future applications, novel compounds, and areas for further research
Covers topics by authors who are renowned experts and researchers in the field

Produktdetails

• Verlag: Wiley & Sons
• 1. Auflage
• Seitenzahl: 360
• Erscheinungstermin: 22. Juni 2015
• Englisch
• Abmessung: 241mm x 159mm x 27mm
• Gewicht: 666g
• ISBN-13: 9781118521533
• ISBN-10: 1118521536
• Artikelnr.: 40557270

Autorenporträt

Alicja Hubalewska-Dydejczyk, PhD, MD, is Professor of Endocrinology and Nuclear Medicine, and Head of the Chair and Department of Endocrinology at the Jagiellonian University's Medical College (Cracow, Poland). Alberto Signore, MD, is Professor of Nuclear Medicine and Physician in the Department of Medical-Surgical Sciences and Translational Medicine of the Faculty of Medicine and Psychologu of "Sapienza" University in Rome, Italy. Marion de Jong, PhD, is Professor of Nuclear Biology at the Departments of Nuclear Medicine and Radiology of the Erasmusc MC in Rotterdam, The Netherlands. Rudi A. Dierckx, PhD, is Head of the Department of Nuclear Medicine and Molecular Imaging at the University Medical Center Groningen, University of Groningen, the Netherlands. John Buscombe, MD, is a Consultant Physician in Nuclear Medicine Addenbrooke's Hospital (Cambridge, UK) and Honorary Professor in Nuclear Medicine at the University of Pretoria, South Africa. Christophe Van de Wiele, PhD, is Full Professor at the University of Ghent, Belgium.

Inhaltsangabe

Contributors viii Preface xii Acknowledgements xv 1 Somatostatin: The
History of Discovery 1 Malgorzata Trofimiuk-Müldner and Alicja
Hubalewska-Dydejczyk 2 Physiology of Endogenous Somatostatin Family:
Somatostatin Receptor Subtypes, Secretion, Function and Regulation, and
Organ Specific Distribution 6 Marily Theodoropoulou 3 Somatostatin
Receptors in Malignancies and Other Pathologies 21 Marco Volante, Adele
Cassenti, Ida Rapa, Luisella Righi, and Mauro Papotti 4 The Use of
Radiolabeled Somatostatin Analogue in Medical Diagnosis: Introduction 31
Alberto Signore 4.1 Somatostatin Receptor Scintigraphy-SPECT 35 Renata
MikoBajczak and Alberto Signore 4.2 Molecular Imaging of Somatostatin
Receptor-Positive Tumors Using PET/CT 55 Richard P. Baum and Harshad R.
Kulkarni 4.3 Other Radiopharmaceuticals for Imaging GEP-NET 75 Klaas Pieter
Koopmans, Rudi A. Dierckx, Philip H. Elsinga, Thera P. Links, Ido P. Kema,
Helle-Brit Fiebrich, Annemieke M.E. Walekamp, Elisabeth G.E. de Vries, and
Adrienne H. Brouwers 4.4 The Place of Somatostatin Receptor Scintigraphy in
Clinical Setting: Introduction 86 Alicja Hubalewska-Dydejczyk 4.4.1
Somatostatin Receptor Scintigraphy in Management of Patients with
Neuroendocrine Neoplasms 90 Anna Sowa-Staszczak, Agnieszka StefaDska, Agata
Jabrocka-Hybel, and Alicja Hubalewska-Dydejczyk 4.4.2 The Place of
Somatostatin Receptor Scintigraphy and Other Functional Imaging Modalities
in the Setting of Pheochromocytoma and Paraganglioma 112 Alicja
Hubalewska-Dydejczyk, Henri J.L.M. Timmers, and Malgorzata
Trofimiuk-Müldner 4.4.3 Somatostatin Receptor Scintigraphy in Medullary
Thyroid Cancer 127 Anouk N.A. van der Horst-Schrivers, Adrienne H.
Brouwers, and Thera P. Links 4.4.4 Somatostatin Receptor Scintigraphy in
Other Tumors Imaging 135 Malgorzata Trofimiuk-Müldner and Alicja
Hubalewska-Dydejczyk 4.4.5 Somatostatin Receptor Scintigraphy in
Inflammation and Infection Imaging 153 Alberto Signore, Kelly Luz Anzola
Fuentes, and Marco Chianelli 5 Somatostatin Analogues in Pharmacotherapy:
Introduction 164 Wouter W. de Herder 5.1 Somatostatin Analogues in
Pharmacotherapy 166 Wouter W. de Herder 5.2 Pituitary Tumor Treatment with
Somatostatin Analogues 169 Alicja Hubalewska-Dydejczyk, Aleksandra
Gilis-Januszewska, and Malgorzata Trofimiuk-Müldner 5.3 Somatostatin
Analogues in Pharmacotherapy of Gastroenteropancreatic Neuroendocrine
Tumors 189 Frédérique Maire and Philippe Ruszniewski 5.4 Somatostatin
Analogue Use in Other than Endocrine Tumor Indications 198 Aleksandra
Gilis-Januszewska, Malgorzata Trofimiuk-Müldner, Agata Jabrocka-Hybel,, and
Dorota Pach 6 Peptide Receptor Radionuclide Therapy Using Radiolabeled
Somatostatin Analogues: An Introduction 207 John Buscombe 6.1 Somatostatin
Analogues and Radionuclides Used in Therapy 214 Esther I. van Vliet, Boen
L.R. Kam, Jaap J.M. Teunissen, Marion de Jong, Eric P. Krenning, and Dik J.
Kwekkeboom 6.2 PRRT Dosimetry 230 Mark Konijnenberg 6.3 Peptide Receptor
Radionuclide Therapy (PRRT): Clinical Application 252 Lisa Bodei, and
Giovanni Paganelli 6.4 Duo-PRRT of Neuroendocrine Tumors Using Concurrent
and Sequential Administration of Y-90- and Lu-177-Labeled Somatostatin
Analogues 264 Richard P. Baum and Harshad R. Kulkarni 6.5 N onsystemic
Treatment of Liver Metastases from Neuroendocrine Tumor 273 Daniel Putzer,
Gerlig Widmann, Dietmar Waitz, Werner Jaschke, and Irene J. Virgolini 6.6
Peptide Receptor Radionuclide Therapy: Other Indications 282 Agnieszka
StefaDska, Alicja Hubalewska-Dydejczyk, Agata Jabrocka-Hybel, and Anna
Sowa-Staszczak 7 Somatostatin Analogs: Future Perspectives and Preclinical
Studies--Pansomatostatins 291 Aikaterini Tatsi Berthold A. Nock, Theodosia
Maina, and Marion de Jong 8 Radiolabeled Somatostatin Receptor Antagonists
305 Melpomeni Fani and Helmut R. Maecke 9 Cortistatins and Dopastatins 321
Manuela Albertelli and Diego Ferone Index 000